Red Rock Regeneration Inc

Red Rock Regeneration Inc is an early-stage biotechnology company based in Etobicoke, Toronto, Ontario, Canada. The company specializes in regenerative medicine, focusing on the development of effective and affordable tissue and recombinant growth factor-derived products. It operates primarily in scientific research and development services within the biotech and health sectors.

Recognized for its rapid growth, Red Rock Regeneration topped Deloitte Canada's 2025 Technology Fast 50 program with an impressive three-year revenue growth rate of 12,166%. The company employs between 100 to 250 people and is a member of OBIO®. Cameron Clokie serves as the Director and Board Member, leading the company's innovative efforts in the biotech field.